Endometrial preparation for frozen-thawed embryo transfer in an artificial cycle: transdermal versus vaginal estrogen

The objective was to compare the endometrial thickness (ET) in a frozen embryo transfer (FET) cycle between transdermal and vaginal estrogen. Our secondary objectives were to compare the patient satisfaction and the pregnancy outcomes. Prospective monocentric cohort study between 01/2017 and 12/2017 at a single institution. Choice of administration was left to the patient. 119 cycles had transdermal estrogen (T-group) and 199 had vaginal estrogen (V-group). The ET at 10 +/- 1 days of treatment was significantly higher in the T-group compared to the V-group (9.9 vs 9.3mm, p=0.03). In the T-group, the mean duration of treatment was shorter (13.6 vs 15.5 days, p<0.001). The rate of cycle cancelation was comparable between the two groups (12.6% vs 8.5%, p=0.24). Serum estradiol levels were significantly lower (268 vs 1332pg/ml, p<0.001), and serum LH levels were significantly higher (12.1 +/- 16.5 vs 5 +/- 7.5 mIU/ml, p<0.001) in the T-group. Patient satisfaction was higher in the T-group (p=0.04) and 85.7% (36/42) of women who had received both treatments preferred the transdermal over the vaginal route. Live birth rates were comparable between the two groups (18% vs 19%, p=0.1). Transdermal estrogen in artificial FET cycles was associated with higher ET, shorter treatment duration and better tolerance.